Buy Naprelan

Naprelan

Naprelan: Brand Overview

Naprelan is a prescription-only medication marketed in the United Kingdom that contains the non-steroidal anti-inflammatory drug (NSAID) naproxen as its sole active ingredient. It is supplied as oral pill tablets in two strengths-250 mg and 500 mg-and is formulated as an extended-release preparation to provide prolonged pain relief with once-daily dosing. Naprelan is regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) and must be prescribed by a qualified healthcare professional.

How Naprelan Works in the Body

Naproxen belongs to the NSAID class and exerts its therapeutic effect by inhibiting cyclo-oxygenase (COX) enzymes, primarily COX-1 and COX-2. These enzymes catalyse the conversion of arachidonic acid into prostaglandins, which are lipid compounds that mediate:

• Inflammation
• Pain signalling
• Fever

By reducing prostaglandin synthesis, naproxen diminishes the inflammatory response, lowers the pain threshold, and helps control fever. The extended-release tablet releases naproxen gradually, maintaining steady plasma concentrations over 24 hours, which supports consistent symptom control and may reduce the need for multiple daily doses.

Conditions Treated by Naprelan

Naprelan is approved in the UK for the relief of pain and inflammation associated with:

• Osteoarthritis
• Rheumatoid arthritis
• Ankylosing spondylitis
• Other chronic musculoskeletal conditions requiring long-term NSAID therapy

In clinical practice, physicians may also prescribe naproxen for acute pain such as dental pain, dysmenorrhoea, or post-operative discomfort, provided the patient’s overall health status permits NSAID use.

Patient Suitability and Contraindications

Who Should Use Naprelan?

• Adults who require continuous pain relief from inflammatory musculoskeletal disorders.
• Patients without a history of severe gastrointestinal (GI) ulceration, uncontrolled hypertension, or significant renal impairment.
• Individuals who are not pregnant (especially not in the third trimester) and not breastfeeding without professional advice.

Absolute Contraindications

• Known hypersensitivity to naproxen, other NSAIDs, or any excipients in the tablet.
• Active GI bleeding or a recent (within 30 days) perforated ulcer.
• Severe renal impairment (e.g., creatinine clearance < 30 mL/min).
• Third-trimester pregnancy (risk of premature ductus arteriosus closure and fetal renal dysfunction).
• Patients taking aspirin for coronary artery disease in combination with other NSAIDs (increased bleeding risk).

Relative Contraindications & Special Populations

• Mild to moderate renal insufficiency - dose adjustment and close monitoring may be needed.
• Mild hepatic dysfunction - use with caution; monitor liver enzymes.
• Elderly patients - higher susceptibility to GI, renal, and cardiovascular adverse events; start at the lowest effective dose.
• History of asthma or nasal polyps triggered by NSAIDs - risk of bronchospasm; consider alternative analgesics.

Safety Profile: Side Effects and Interactions

Common Side Effects

• Upper abdominal discomfort (indigestion, heartburn)
• Nausea or mild vomiting
• Headache or dizziness
• Transient rash or mild pruritus

These effects are usually mild and resolve with continued therapy or by taking the tablet with food.

Serious Adverse Events

• GI ulceration or bleeding - may present as black stools, vomiting blood, or abdominal pain.
• Cardiovascular events (myocardial infarction, stroke) - risk increases with long-term high-dose use.
• Renal toxicity - reduced urine output, swelling, or elevated creatinine.
• Severe hypersensitivity reactions - angio-edema, anaphylaxis, severe skin reactions (e.g., Stevens-Johnson syndrome).
• Liver injury - jaundice, dark urine, elevated liver enzymes.

Any of these serious symptoms warrant immediate medical evaluation.

Drug Interactions

• Anticoagulants (e.g., warfarin) - increased bleeding risk.
• Other NSAIDs or aspirin - additive GI toxicity.
• Selective serotonin reuptake inhibitors (SSRIs) - heightened bleeding risk.
• ACE inhibitors, ARBs, or diuretics - possible reduction in renal perfusion; monitor renal function.
• Lithium - naproxen may raise lithium levels, risking toxicity.
• Methotrexate - NSAIDs can reduce its clearance, increasing toxicity.
• Cyclosporine - enhanced nephrotoxicity.

Patients should disclose all prescription medicines, over-the-counter drugs, herbal supplements, and vitamins to their prescriber before starting Naprelan.

Food and Lifestyle Interactions

• Take with food or milk to minimise gastric irritation.
• Limit alcohol as it can exacerbate GI bleeding risk.
• Avoid driving if dizziness occurs; naproxen does not typically impair motor function but individual responses vary.
• Sun exposure - no direct photosensitivity, but impaired healing of sunburns may occur in NSAID users.

Dosing and Administration Guidelines

• Standard dosing: The typical recommended dose for the extended-release formulation is one tablet (250 mg or 500 mg) taken once daily, preferably in the morning with a full glass of water and food.
• Dose adjustment: For patients with reduced renal or hepatic function, clinicians may initiate therapy at the lower 250 mg strength and reassess tolerance.
• Missed dose: If a dose is forgotten, take it as soon as remembered unless the next scheduled dose is within 4-6 hours; in that case, skip the missed tablet and continue with the regular regimen. Do not double-dose.
• Overdose: Symptoms may include nausea, vomiting, abdominal pain, drowsiness, or gastrointestinal bleeding. Immediate medical attention is required; activated charcoal may be administered if presentation is early.
• Discontinuation: For short courses, stopping abruptly is acceptable. For long-term therapy, a gradual taper is advisable to monitor for recurrent pain and to reduce the risk of rebound inflammation.

Important: All dosing decisions must be personalised by the prescribing clinician based on the patient’s medical history and response to therapy.

Monitoring and Follow-Up

Patients receiving Naprelan for chronic conditions should undergo periodic evaluation, which may include:

• Renal function tests (serum creatinine, eGFR) every 3-6 months.
• Liver enzymes (ALT, AST) if there is pre-existing hepatic disease.
• Blood pressure monitoring, especially in those with cardiovascular risk factors.
• Complete blood count if signs of anemia or bleeding appear.
• Assessment of GI symptoms - any new dyspepsia, black stools, or abdominal pain should prompt review.

Regular follow-up appointments enable clinicians to adjust therapy, address side effects, and ensure safe long-term use.

Storage and Handling

• Store tablets at room temperature (≤ 25 °C), protected from excess moisture and direct sunlight.
• Keep the medication out of reach of children; use child-proof containers if available.
• Do not use tablets beyond the expiry date printed on the packaging.
• Dispose of unused tablets according to local pharmacy take-back schemes or the MHRA’s waste-disposal guidelines.

Medication-Specific Glossary

COX Enzyme

Cyclo-oxygenase enzymes (COX-1 and COX-2) that catalyse prostaglandin formation, driving inflammation and pain.

Extended-Release

A pharmaceutical formulation designed to release the active ingredient slowly over an extended period, allowing once-daily dosing.

Gastrointestinal Ulcer

A sore on the lining of the stomach or duodenum that can bleed; NSAIDs increase the risk by inhibiting protective prostaglandins.

Renal Impairment

Reduced kidney function that hampers the body’s ability to filter waste; NSAIDs may further decrease renal blood flow.

Prostaglandin

Lipid compounds that mediate inflammation, fever, and pain; their synthesis is blocked by NSAIDs like naproxen.

Medical Disclaimer

This article provides educational information about Naprelan and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.